Bicycle Therapeutics clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   BT8009-100 · Nectin-4 Expressing Advanced Malignancies

   Primary completion pushed from Mar 2026 to Jan 2027

   BicycleTx Limited·Phase 1/2· NCT04561362· Registry history of NCT04561362 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.